NICE recommends first ever treatment for children with rare muscle-wasting condition

Children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with nusinersen after NICE today (15 May) recommended it following agreement of a deal between the company, Biogen, and NHS England.

Read article

Lower price for MS drug paves the way for positive recommendation from NICE

A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults has paved the way for its approval by NICE

Read article

New NICE guideline will help doctors recognise and refer people with suspected neurological conditions

NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.

Read article

NICE launches online resource to help development and adoption of new health technologies

HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies as they move from inception to adoption in the UK health and care system was formally launched today (29 April).

Read article

Latest news headlines